Adage Capital Partners GP L.L.C. increased its position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 21.7% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 56,000 shares of the company's stock after buying an additional 10,000 shares during the period. Adage Capital Partners GP L.L.C.'s holdings in Option Care Health were worth $1,957,000 at the end of the most recent reporting period.
A number of other hedge funds have also bought and sold shares of the company. Northwestern Mutual Wealth Management Co. increased its stake in Option Care Health by 1,492.9% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 892 shares of the company's stock valued at $31,000 after purchasing an additional 836 shares in the last quarter. Brooklyn Investment Group increased its stake in Option Care Health by 186.6% in the first quarter. Brooklyn Investment Group now owns 1,198 shares of the company's stock valued at $42,000 after purchasing an additional 780 shares in the last quarter. Bessemer Group Inc. increased its stake in Option Care Health by 62.3% in the first quarter. Bessemer Group Inc. now owns 1,560 shares of the company's stock valued at $54,000 after purchasing an additional 599 shares in the last quarter. Public Employees Retirement System of Ohio increased its stake in Option Care Health by 21.6% in the fourth quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock valued at $43,000 after purchasing an additional 332 shares in the last quarter. Finally, Wealthquest Corp bought a new stake in Option Care Health in the first quarter valued at $66,000. Institutional investors own 98.05% of the company's stock.
Analyst Upgrades and Downgrades
Several research firms have weighed in on OPCH. Barrington Research reaffirmed an "outperform" rating and issued a $38.00 price target on shares of Option Care Health in a research note on Thursday, July 10th. JMP Securities lifted their price target on shares of Option Care Health from $36.00 to $38.00 and gave the company a "market outperform" rating in a research note on Thursday, July 31st. Finally, Citigroup reaffirmed an "outperform" rating on shares of Option Care Health in a research note on Thursday, July 31st. Eight research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $35.75.
Get Our Latest Research Report on Option Care Health
Option Care Health Stock Down 3.0%
Option Care Health stock traded down $0.89 during midday trading on Friday, hitting $28.48. 1,626,043 shares of the stock were exchanged, compared to its average volume of 1,842,623. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $35.53. The stock has a market capitalization of $4.62 billion, a price-to-earnings ratio of 22.78, a price-to-earnings-growth ratio of 1.79 and a beta of 0.82. The business's 50-day moving average price is $29.09 and its 200-day moving average price is $31.43. The company has a quick ratio of 1.00, a current ratio of 1.52 and a debt-to-equity ratio of 0.81.
Option Care Health (NASDAQ:OPCH - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.01. Option Care Health had a net margin of 3.93% and a return on equity of 17.53%. The business had revenue of $1.42 billion for the quarter, compared to analysts' expectations of $1.35 billion. During the same period in the previous year, the company earned $0.30 earnings per share. The firm's revenue for the quarter was up 15.4% compared to the same quarter last year. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. On average, research analysts expect that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.
Insiders Place Their Bets
In related news, Director Timothy P. Sullivan acquired 20,000 shares of the stock in a transaction on Thursday, August 21st. The shares were acquired at an average price of $27.51 per share, with a total value of $550,200.00. Following the completion of the transaction, the director owned 49,229 shares in the company, valued at approximately $1,354,289.79. The trade was a 68.43% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Norman L. Wright acquired 3,411 shares of the stock in a transaction on Tuesday, September 9th. The stock was bought at an average cost of $29.31 per share, for a total transaction of $99,976.41. Following the transaction, the director owned 15,501 shares of the company's stock, valued at approximately $454,334.31. This trade represents a 28.21% increase in their position. The disclosure for this purchase can be found here. Over the last 90 days, insiders have purchased 59,411 shares of company stock valued at $1,627,576. Company insiders own 0.64% of the company's stock.
Option Care Health Profile
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Recommended Stories

Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.